Oxyjun
Also known as: Arjuna, OxyjunTM, Terminalia arjuna
Overview
OxyjunTM is a premium branded extract sourced from the bark of the Terminalia arjuna tree, widely recognized in Ayurvedic medicine for its cardioprotective properties. This herbal supplement primarily aims to enhance cardiovascular health, mitigate systemic inflammation, and bolster physical performance. It is rich in bioactive compounds such as flavonoids, glycosides, and tannins, which contribute to its therapeutic effects. Although research on OxyjunTM is in the emerging phase, several recent clinical trials have investigated its efficacy, indicating potential benefits for heart health and energy levels. However, further comprehensive studies are needed to confirm its long-term outcomes and safety.
Benefits
Evidence suggests that OxyjunTM can enhance cardiac output and reduce systemic inflammation. A clinical trial with 72 subjects indicated a significant 6.28% increase in cardiac output after consistent intake of 400 mg daily for 56 days. Additional studies reported reductions in the neutrophil lymphocyte ratio (NLR) by 0.71 and a notable 22.5% decrease in perceived physical fatigue. While the increase in HDL cholesterol levels and quality of life metrics also showed promise, they require further validation due to non-statistical significance in some cases. The strongest benefits appear for overweight individuals and adults aged 30-70, highlighting its potential as a cardiac health supplement.
How it works
OxyjunTM exerts its effects mainly through its bioactive constituents, which may provide anti-inflammatory and antioxidant benefits. It supports the cardiovascular system by enhancing cardiac output and decreasing inflammation markers, impacting overall heart function. Although specific molecular targets are not fully determined, it is believed to modulate cytokine levels relating to inflammation and improve endothelial function critical for cardiovascular health. The observed clinical benefits suggest sufficient absorption, although bioavailability studies are necessary.
Side effects
Current studies report a good safety profile for OxyjunTM, with no common adverse effects exceeding 5% and no rare or uncommon effects noted. Specific drug interactions remain undetermined; caution is advised if taken alongside cardiovascular medications. While no contraindications are explicitly mentioned, it is recommended for use under medical supervision in individuals with pre-existing cardiovascular conditions. Pregnant or breastfeeding women and those with severe health concerns should consult a healthcare provider before use. Overall, the safety findings are encouraging, but long-term safety data is still needed to solidify these claims.
Dosage
The recommended dosage for OxyjunTM is around 400 mg daily based on recent clinical trials. No established minimum effective dose exists, but studies indicated positive outcomes with this dosage over periods of 56 days or 8 weeks. The maximum safe dose has yet to be determined; however, no adverse effects were reported within tested ranges. Consistency in daily intake is crucial for effectiveness, with the supplement typically in capsule or tablet form. While absorption is presumed adequate, further research would enhance understanding of factors affecting its bioavailability.
FAQs
Is OxyjunTM safe to use?
Yes, studies suggest OxyjunTM has a good safety profile, although long-term data is limited.
When should I take OxyjunTM?
OxyjunTM can be taken at any time of the day, but consistency in daily intake is advisable.
What results can I expect from OxyjunTM?
Users may experience improved cardiac output, reduced inflammation, and less physical fatigue.
Can OxyjunTM replace my medications?
No, it is a supplement intended to support cardiovascular health, not a substitute for prescribed treatments.
Research Sources
- https://ijpefs.org/index.php/ijpefs/article/view/323 – A randomized controlled trial involving 60 participants indicated that OxyjunTM significantly reduced systemic inflammation and improved HDL levels while enhancing quality of life metrics over an 8-week period.
- https://pubmed.ncbi.nlm.nih.gov/38547136/ – Research featuring 72 subjects showed that OxyjunTM led to a notable increase in cardiac output and decrease in perceived fatigue over 56 days. These findings support its use in improving cardiovascular function.
